ArticleQuantitative imaging in medicine and surgery2026
Ultrasonic markers for screening intra-abdominal hypertension in patients with pancreatic diseases.
Article in Quantitative imaging in medicine and surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Accurately assessing intra-abdominal hypertension (IAH) is of significant clinical importance in laparoscopic pancreaticoduodenectomy (LPD) and severe acute pancreatitis (SAP), which is closely linked to complications and mortality. This study aimed to identify potential ultrasonic markers for screening IAH in patients who underwent LPD for pancreatic cancer and those with SAP. Methods: We conducted a retrospective analysis of 27 patients who were diagnosed with pancreatic cancer and underwent LPD, and 19 patients with SAP admitted to the intensive care unit (ICU) from February 2022 to August 2022. Baseline demographic, ultrasonic markers, and clinical records were obtained and analyzed to identify potential ultrasonic markers for screening IAH. The diagnostic performance was assessed using the area under the receiver operating characteristic (ROC) curve (AUROC). Results: Comparative analysis between the two groups showed that in both the LPD and SAP groups, patients with IAH exhibited significantly lower right diaphragm thickening rate (RDTR) and significantly higher right renal interlobar arterial resistive index (RIRI) than those without IAH (all P<0.05). Univariate analysis and multivariate regression analysis showed that the RIRI and RDTR were independent predictors of IAH in the LPD group (P=0.004 and P=0.025, respectively); and the combination of RIRI and RDTR showed promising diagnostic performance for IAH, with an AUROC of 0.894, sensitivity of 93.33%, and specificity of 91.67%. Meanwhile, for the SAP group, only the RDTR served as the marker for screening IAH with an AUROC of 0.872, a sensitivity of 86.67%, and a specificity of 83.33%. Conclusions: This preliminary study suggests that clinicians should remain alert to the occurrence of IAH when abnormal ultrasonic markers are screened. Regular intra-abdominal pressure monitoring is recommended in such cases. However, these findings require validation in larger prospective cohorts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.